Rick Pearson

Citata da

	Tutte	Dal 2019
Citazioni	21193	6593
Indice H	75	48
i10-index	133	97

1400

700

350

1050

19861987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023202460 80 107 148 179 293 329 375 435 352 421 376 377 403 330 330 394 334 360 409 413 375 424 428 473 505 578 786 838 857 857 857 877 967 1076 1352 1105 1094 983

Accesso pubblico

Visualizza tutto

68 articoli

8 articoli

Disponibili

Non disponibili

In base ai mandati di finanziamento

Coautori

Ross HannanProfessor Ross Hannan, Centenary Chair of Cancer Research, Deputy Dean of ResearchEmail verificata su anu.edu.au
Professor Rod HicksDepartment of Medicine, St Vincent's Hospital, the University of Melbourne and Department ofEmail verificata su mtic.net.au
Professor Tony PapenfussTheme Leader, Computational Biology, Walter and Eliza Hall Institute of MedicalEmail verificata su wehi.edu.au
Lawrence RothblumUniversity of Oklahoma College of medicineEmail verificata su ouhsc.edu
Megan AstleMonash UniversityEmail verificata su monash.edu
Amee J GeorgeAustralian National UniversityEmail verificata su anu.edu.au
Steven BozinovskiProfessor, RMIT UniversityEmail verificata su rmit.edu.au
Michael S. AnglesioAssistant Professor, Department of Obstetrics & Gynaecology, University of British ColumbiaEmail verificata su ubc.ca
Lee WongMonash UniversityEmail verificata su monash.edu
Joshy GeorgeDirector, Computational Sciences, Jackson Laboratory for Genomic Medicine, ConnecticutEmail verificata su jax.org
Nicholas VeldhuisMonash UniversityEmail verificata su monash.edu
Aimin XuDepartment of Medicine, Department of Pharmacology and Pharmacy, the University of Hong KongEmail verificata su hku.hk
Charbel DaridoGroup Leader, Peter MacCallum Cancer Centre. Senior Research Fellow, The Alfred Hospital - MonashEmail verificata su monash.edu
Professor Stephen JaneMonash UniversityEmail verificata su monash.edu
Theo MantamadiotisThe University of MelbourneEmail verificata su unimelb.edu.au
Cavanaugh AResearch Scientist II Weis Center for ResearchEmail verificata su geisinger.edu
Alexander DobrovicUniversity of Melbourne Department of SurgeryEmail verificata su unimelb.edu.au
Phillip J RobinsonChildren's Medical Research InstituteEmail verificata su cmri.org.au
Jim WoodgettSenior Scientist, Lunenfeld-Tanenbaum Research InstituteEmail verificata su lunenfeld.ca
Pier Paolo PandolfiDirector, Cancer Center and Cancer Research Institute, Beth Israel Deaconess Medical CenterEmail verificata su bidmc.harvard.edu

Segui

Rick Pearson

Group Leader, Peter MacCallum Cancer Centre

Email verificata su petermac.org

Cancer Biology


Titolo Ordina per citazioni Ordina per anno Ordina per titolo	Citata da Citata da	Anno
[3] Protein kinase phosphorylation site sequences and consensus specificity motifs: Tabulations RB Pearson, BE Kemp Methods in enzymology 200, 62-81, 1991	1314	1991
Protein kinase recognition sequence motifs BE Kemp, RB Pearson Trends in biochemical sciences 15 (9), 342-346, 1990	1302	1990
Rapamycin suppresses 5′ TOP mRNA translation through inhibition of p70s6k HBJ Jefferies, S Fumagalli, PB Dennis, C Reinhard, RB Pearson, ... The EMBO journal, 1997	1211	1997
Mutation of the PIK3CA gene in ovarian and breast cancer IG Campbell, SE Russell, DYH Choong, KG Montgomery, ML Ciavarella, ... Cancer research 64 (21), 7678-7681, 2004	1164	2004
A potent synthetic peptide inhibitor of the cAMP-dependent protein kinase. HC Cheng, BE Kemp, RB Pearson, AJ Smith, L Misconi, SM Van Patten, ... Journal of Biological Chemistry 261 (3), 989-992, 1986	655	1986
The Akt kinase signals directly to endothelial nitric oxide synthase BJ Michell, JE Griffiths, KI Mitchelhill, I Rodriguez-Crespo, T Tiganis, ... Current biology 9 (15), 845-848, 1999	619	1999
Inhibition of RNA polymerase I as a therapeutic strategy to promote cancer-specific activation of p53 MJ Bywater, G Poortinga, E Sanij, N Hein, A Peck, C Cullinane, M Wall, ... Cancer cell 22 (1), 51-65, 2012	589	2012
mTOR-dependent regulation of ribosomal gene transcription requires S6K1 and is mediated by phosphorylation of the carboxy-terminal activation domain of the nucleolar … KM Hannan, Y Brandenburger, A Jenkins, K Sharkey, A Cavanaugh, ... Molecular and cellular biology, 2003	586	2003
The principal target of rapamycin‐induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. RB Pearson, PB Dennis, JW Han, NA Williamson, SC Kozma, ... The EMBO journal 14 (21), 5279-5287, 1995	555	1995
Coordinate regulation of ribosome biogenesis and function by the ribosomal protein S6 kinase, a key mediator of mTOR function K Jastrzebski, KM Hannan, EB Tchoubrieva, RD Hannan, RB Pearson Growth factors 25 (4), 209-226, 2007	318	2007
Response of BRAF-Mutant Melanoma to BRAF Inhibition Is Mediated by a Network of Transcriptional Regulators of Glycolysis TJ Parmenter, M Kleinschmidt, KM Kinross, ST Bond, J Li, MR Kaadige, ... Cancer discovery 4 (4), 423-433, 2014	304	2014
STIM1: a novel phosphoprotein located at the cell surface SSM Manji, NJ Parker, RT Williams, L Van Stekelenburg, RB Pearson, ... Biochimica et Biophysica Acta (BBA)-Protein Structure and Molecular …, 2000	293	2000
AKT induces senescence in human cells via mTORC1 and p53 in the absence of DNA damage: implications for targeting mTOR during malignancy MV Astle, KM Hannan, PY Ng, RS Lee, AJ George, AK Hsu, Y Haupt, ... Oncogene 31 (15), 1949-1962, 2012	291	2012
Targeting PI3 kinase/AKT/mTOR signaling in cancer K Sheppard, KM Kinross, B Solomon, RB Pearson, WA Phillips Critical Reviews™ in Oncogenesis 17 (1), 2012	291	2012
The calmodulin binding domain of chicken smooth muscle myosin light chain kinase contains a pseudosubstrate sequence. BE Kemp, RB Pearson, V Guerriero Jr, IC Bagchi, AR Means Journal of Biological Chemistry 262 (6), 2542-2548, 1987	287	1987
Substrate specificity of a multifunctional calmodulin-dependent protein kinase. RB Pearson, JR Woodgett, P Cohen, BE Kemp Journal of Biological Chemistry 260 (27), 14471-14476, 1985	284	1985
Targeting the nucleolus for cancer intervention JE Quin, JR Devlin, D Cameron, KM Hannan, RB Pearson, RD Hannan Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1842 (6), 802-816, 2014	281	2014
Targeting of the tumor suppressor GRHL3 by a miR-21-dependent proto-oncogenic network results in PTEN loss and tumorigenesis C Darido, SR Georgy, T Wilanowski, S Dworkin, A Auden, Q Zhao, ... Cancer cell 20 (5), 635-648, 2011	263	2011
Ribosomal proteins and human diseases: molecular mechanisms and targeted therapy J Kang, N Brajanovski, KT Chan, J Xuan, RB Pearson, E Sanij Signal transduction and targeted therapy 6 (1), 323, 2021	256	2021
UBF levels determine the number of active ribosomal RNA genes in mammals E Sanij, G Poortinga, K Sharkey, S Hung, TP Holloway, J Quin, E Robb, ... The Journal of cell biology 183 (7), 1259-1274, 2008	254	2008

Il sistema al momento non può eseguire l'operazione. Riprova più tardi.

Articoli 1–20

Citazioni per anno

Citazioni duplicate

Citazioni unite

Aggiungi coautoriCoautori

Segui

Citata da

Coautori